Emcure Pharmaceuticals IPO subscription status: The initial public offering of Emcure Pharmaceuticals Ltd has kicked off for subscriptions today (Wednesday, July 3) and has smoothly sailed through its first bidding day, getting fully booked. Emcure Pharma IPO subscription status is 1.32 times, as per BSE data. The quota for non-institutional investors received 2.71 times subscription …
Emcure Pharmaceuticals IPO: The mainboard initial public offering (IPO) of leading pharma major Emcure Pharmaceuticals Ltd will open for subscription on Wednesday, July 3, 2024. The company develops and manufactures various pharmaceutical products across several major therapeutic areas. Emcure Pharma’s product portfolio consists of injectables, biotherapeutics, and orals. The research and development (R&D)-driven firm has …
Emcure Pharmaceuticals IPO price band: The Emcure Pharmaceuticals Limited IPO price band has been set in the range of ₹960 to ₹1,008 per equity share of the face value of ₹10. The Emcure Pharmaceuticals IPO date of subscription is scheduled for Wednesday, July 3, and will end on Friday, July 5. The allocation to anchor …